Waterdrop Inc. has been included in Harvard Business school’s (HBS) Case Collection. Inducted as a business innovation case, ...

Studies presented at the Society of Neurointerventional Surgery’s show links between GLP-1s and the prevention of strokes and ...

Dr. Ben Zeskind, CEO of Immuneering, discusses the new approach his company is taking to oncology.

Professor MinWoo Kim’s research team newest development, MoGLo-Net, solves the extensive 3D imaging problems. MoGLo-Net is a deep learning model that automatically tracks transducer movements without ...

Corina Dutcus, SVP, oncology global clinical development lead at Eisai, discusses the potential of the E7386 and lenvatinib ...

Health services company Humana announced its first Humana Cognitive Games. 1 The event is designed to give older adults both ...

Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing ...

The SVP of educational development’s contribution to the book displays SKNV’s approach to furthering education and ...

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...

Priority review was based on results from the Phase IIb SunRISe-1 trial, which showed that patients treated with TAR-200 for ...

Research from a recent Cadent study reveals the growing impact of TV and connected TV advertising in raising medication ...

Corina Dutcus, SVP, oncology global clinical development lead, Eisai, explains how E7386 and lenvatinib work together to ...